Canada's rare disease landscape presents a unique opportunity to revolutionize healthcare through a comprehensive, integrated approach. The nation's existing infrastructure and research initiatives offer a strong foundation, but they require strategic enhancements to create a truly transformative system. This article delves into the critical role of data infrastructure in building a learning health ecosystem for rare genetic diseases, highlighting the need for federal leadership, standardized testing, and community engagement.
The Power of Data Sharing
The advent of genomic DNA sequencing has revolutionized rare disease diagnosis, but it's the accompanying data sharing practices that truly unlock its potential. Access to large-scale datasets is crucial for interpreting DNA variants, a process that involves comparing an individual's genetic information to that of thousands of others. This comparison enables the identification of disease-causing variations, a feat that relies on the availability of diverse genomic and clinical data.
In Canada, the All for One Data Sharing Agreement has been instrumental in fostering responsible data exchange between diagnostic laboratories. This agreement, coupled with the Canadian Open Genetics Repository and the Indigenous Background Variant Library, showcases the importance of trusted data sharing, representative reference populations, and governance models that prioritize community partnership and cultural safety. These initiatives are essential for accurate genomic diagnosis, ensuring that genetic tests are interpreted within the context of diverse genetic backgrounds.
The Role of Discovery Research
Accurate diagnosis of rare diseases also hinges on ongoing discovery research. Many patients carry variants in genes not yet definitively linked to disease, requiring research to establish these connections. Care4Rare, a Canadian program, exemplifies this by analyzing genomic data across over 100 countries, utilizing the Matchmaker Exchange to identify new disease-gene relationships. The Pan-Canadian Genome Library further enhances data accessibility, providing a centralized resource for Canadian genomic data sharing.
Building a Comprehensive System
While Canada boasts impressive individual efforts, they fall short of creating a cohesive system. The nation's distributed health system and short-term funding cycles hinder long-term sustainability and integration. A federated approach, where data remains within trusted institutions while adhering to shared standards, governance, and infrastructure, emerges as a potential solution. This aligns with the Pan-Canadian Health Data Strategy's call for stronger data foundations, including federated governance and interoperability.
Four Key Shifts for Success
To make data sharing a routine practice, Canada must undergo four significant transformations:
Federal Leadership: Canada needs to embrace the leadership role in genomic data sharing, akin to countries like England, Australia, and Denmark. This involves creating national strategies and allocating substantial funding over extended periods to ensure a robust and sustainable data infrastructure.
Core Infrastructure Recognition: Data sharing should be recognized as a fundamental component of diagnostic infrastructure. When genomic testing is funded, the associated costs of data sharing, interoperability, and governance should be integrated into the funding model, ensuring a seamless contribution to patient care.
National Standards: Establishing pan-Canadian standards for rare disease testing and data is essential. This includes defining eligibility criteria, laboratory accreditation, professional certification, and standardized data collection for phenotype, genotype, variant interpretation, consent, and outcomes. Adopting and enforcing global standards is crucial for seamless data sharing across various healthcare entities.
Community Engagement: Patients, families, and communities should be integral partners in governance. Their active involvement ensures that data sharing is purposeful, transparent, secure, and aligned with their priorities, fostering trust and accelerating diagnosis, research, and care.
Seizing the Opportunity
Canada stands at a pivotal moment, where every test, diagnosis, and patient experience can contribute to a stronger healthcare system. However, this potential can only be realized by treating data sharing as a core health infrastructure, backed by sustained investment, policy alignment, and coordination across jurisdictions and sectors. By embracing these changes, Canada can create a more integrated, equitable, and efficient system for individuals living with rare genetic diseases, ultimately improving healthcare outcomes for all.
